Scalable AAV Manufacturing, without the Detours
From research-grade plasmids to IND-ready vectors, Andelyn accelerates your gene therapy program with speed, flexibility, and a seamless path from early-phase through commercialization.
Commercial Development is Complex. Your Path Forward Shouldn't Be.
Moving from discovery to IND demands a partner who understands your science, delivers high-quality AAV, and keeps your future scale-up in mind from day one. At Andelyn, we’re built to support exactly that. Whether you’re an academic innovator or a biopharma trailblazer, we offer the technical depth and manufacturing agility to advance your program.
Fewer Handoffs. A More Direct Path to Commercialization.
Fragmented development can turn the path from discovery to manufacturing into a series of technology transfers and potential delays. Andelyn brings development and manufacturing together with the AAV Curator Platform, supporting a more continuous path from early development through IND and commercial production.
Andelyn Partners with Ultragenyx on AAV Commercial Manufacturing
Following FDA approval for MPS IIIA, Andelyn Biosciences is manufacturing Ultragenyx’s UX111 for commercial supply in Columbus, Ohio. This marks the first FDA-approved gene therapy produced using the Andelyn AAV Curator® Platform.
Why Teams Trust Andelyn from Day One
Our history, flexibility, integrated model, and rare-disease mission make us the ideal AAV partner for early-stage developers who need more than a just a vendor.
Speed Meets Flexibility
Rapid delivery of research and TOX grade AAV backed by a team that adapts to your needs.
Built to Scale with You
Our AAV Curator Platform minimizes rework and streamlines transition from bench to BLA, with no tech transfer friction.
One Partner All Phases
From plasmid and viral vector manufacturing to GMP and regulatory support one MSA with one trusted path to IND and beyond.
AAV Curator® from Early Development to Commercial Production
AAV Curator® combines a proven platform foundation with program-specific process optimization, helping you move efficiently from early development toward scalable GMP and comercial production.
Development
Explore AAV designs and establish initial process foundation
Data-driven optimization across upstream, downstream, materials, analytics and quality
Developed on the same manufacturing foundation used to scale forward
Consistent, robust process performance to support clinical supply
Scalable, reliable manufacturing designed for long-term commercial success
See Vector Production Details
Download our Full-Spectrum Gene Therapy Partner document to get additional details about our capabilities to support your early-phase AAV manufacturing needs.
BATCHES
APPROVED
MANUFACTURING
PROGRAMS
SUPPORTING BLA
OF FACILITY SPACE
Let’s Advance Your AAV Program Together
Advance your gene therapy program by learning more about Andelyn Biosciences’ integrated, end-to-end gene therapy manufacturing solutions.
Schedule a discovery consultation.
